Join MDA
A place where individuals and families are at the heart of everything we do.
Meet the 2023 Challenge Opportunity!
Triple your donation.
Volunteer and Empower Lives
Choose from one of many volunteer opportunities and make a difference for people living with neuromuscular diseases.
Santhera Pharmaceuticals (SIX: SANN) announces that it has submitted comprehensive briefing material and a meeting request to the FDA to discuss the filing of a New Drug Application (NDA) for Raxone® (idebenone) for the treatment of DMD patients not taking concomitant glucocorticoids.
